| Date | Time | Source | Headline | Symbol | Company |
| 15/02/2019 | 08:00 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 13/02/2019 | 01:47 | Edgar (US Regulatory) | Schedule 13g | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/06/2018 | 06:35 | Edgar (US Regulatory) | Amended Tender Offer Statement by Issuer (sc To-i/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/05/2018 | 06:20 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/05/2018 | 06:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 23:11 | Edgar (US Regulatory) | Tender Offer Statement by Issuer (sc To-i) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 22:30 | PR Newswire (US) | ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 22:28 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 20:00 | PR Newswire (US) | Amneal and Impax Complete Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/05/2018 | 07:05 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/05/2018 | 08:19 | PR Newswire (US) | Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 30/04/2018 | 20:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 28/04/2018 | 08:50 | PR Newswire (US) | Amneal And Impax Receive FTC Clearance For Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 28/04/2018 | 08:30 | PR Newswire (US) | ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 14/04/2018 | 07:04 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/04/2018 | 03:59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/04/2018 | 21:33 | PR Newswire (US) | Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/04/2018 | 07:24 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |